Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Solid Tumors × Topotecan × Clear all

Phase

Phase 3 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Ovarian Neoplasms 12 Small Cell Lung Carcinoma 7 Carcinoma, Ovarian Epithelial 5 Neoplasms 4 Uterine Cervical Neoplasms 3 Leukemia, Myeloid, Acute 3 Leukemia 3 Fallopian Tube Neoplasms 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroblastoma 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Lung Neoplasms 2 Leukemia, Myelomonocytic, Chronic 2 Anemia, Refractory, with Excess of Blasts 2 Thrombocytopenia 1 Solid Tumors 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 SCLC, Extensive Stage 1 Recurrence 1 Radiation Injuries 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Peritoneal Neoplasms 1 Myoepithelioma 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Liposarcoma, Myxoid 1

Interventions

pembrolizumab 4 Nivolumab 2 Injections 2 Docetaxel 2 taxane 1 pazopanib 1 palbociclib 1 lenvatinib 1 demplatin pegraglumer 1 cobimetinib 1 birinapant 1 Topotecan 1 Tablets 1 ODM-207 1 Infusions, Intravenous 1 HLA-A*24:02 antigen 1 Gemcitabine 1 E-3810 1 CB-839 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02303028 2022-06-28

TOPAZ

The Hospital for Sick Children

Phase 1/2 Completed

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡